Reference
- Dyck PJ, Zimmerman BR, Vilen TH, et al. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988: 319(9): 542–8
Reference
- Pfeifer MA, Ross DR, Schrage JP, et al. A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 1993; 10(8): 1103–15
Reference
- Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43(4): 817–24
- The DCCT Research Group. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 1988; 37(4): 476–81
- Sosenko JM, Gadia MT, Fournier AM, et al. Body stature as a risk factor for diabetic sensory neuropathy. Am J Med 1986; 80(6): 1031–4
- Ross MA. Neuropathies associated with diabetes. Med Clin North Am 1993; 77(1): 111–24
- McCulloch DK, Campbell IW, Wu FC, et al. The prevalence of diabetic impotence. Diabetologia 1980; 18(4): 279–83
- McCulloch DK, Young RJ, Prescott RJ, et al. The natural history of impotence in diabetic men. Diabetologia 1984; 26(6): 437–40
- Asbury AK. Proximal diabetic neuropathy. Ann Neurol 1977; 2(3): 179–80
- Casey EB, Harrison MJ. Diabetic amyotrophy: a follow-up study. Br Med J 1972; 1(801): 656–9
- Walsh TJ. Neuro-ophthalmology: clinical signs and symptoms. 3d ed. Philadelphia: Lea & Febiger, 1992: 136
- Stevens JC, Beard CM, O'Fallon WM, et al. Conditions associated with carpal tunnel syndrome. Mayo Clin Proc 1992; 67(6): 541–8
- de Krom MC, Kester AD, Knipschild PG, et al. Risk factors for carpal tunnel syndrome. Am J Epidemiol 1990; 132(6): 1102–10
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977–86
- Fore WW. Noninsulin-dependent diabetes mellitus: the prevention of complications. Med Clin North Am 1995; 79(2): 287–98
- Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1(3): 168–88
- Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulindependent diabetes mellitus. N Engl J Med 1995; 333(2): 89–94
- Boel E, Selmer J, Flodgaard HJ, et al. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise? J Diabetes Complications 1995; 9(2): 104–29
- Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995; 52(11): 1053–61
- Younger DS, Rosoklija G, Hays AP, et al. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve 1996; 19(6): 722–7
- Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326(19): 1250–6
- Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332(18): 1210–7
- Laycock MA, Pascuzzi RM. The neuromuscular effects of hypothyroidism. Semin Neurol 1991; 11(3): 288–94 Women's healthcare